Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Cartilage Technologies, Inc.

This article was originally published in The Tan Sheet

Executive Summary

Cartilage Technologies, Inc.: Announces plans to distribute Cartilade shark cartilage via drug wholesalers and brokers. Morgan Sampson Pacific, Pinnacle Sales, Florida Marketing, Hynes Sales, Ed Hockfield Associates and Ken Madden Associates have come on board as brokers. Drug wholesaler Bergen Brunswig also has agreed to carry the product, CTI said, adding that it is in negotiations with McKesson, FoxMeyer, and Alco. Cartilade has been on shelves in some independent pharmacies and "most health food stores" for about five years, the company said. CTI and Bergen Brunswig plan "major promotions" beginning in August, when radio and print ads will tout Cartilade as an "ideal source of...dietary calcium and phosphorus" as well as an antigenesis inhibitor that "may alleviate the discomfort and reduced mobility associated with joint conditions"..

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS083917

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel